Monte Rosa Therapeutics (GLUE) is transitioning from an oncology focus to a next-gen immunology & inflammation (I&I) platform, with significant pharma partnerships. GLUE's pipeline features MRT-6160 (VAV1 degrader, partnered with Novartis), MRT-8102 (NEK7 degrader), and MRT-2359 (oncology), offering both I&I and oncology upside. Strong financial position with ~$400M cash, multiple lucrative deals with Novartis and Roche, and a cash runway through 2028 reduce near-term dilution risk.
Marti Technologies, Inc. (NYSE:MRT ) Q2 2025 Earnings Call September 22, 2025 8:30 AM EDT Company Participants Oguz Oktem - Founder, CEO & Chairman Cankut Durgun Conference Call Participants Theodore O'Neill - Litchfield Hills Research, LLC John Halpert - Cantor Fitzgerald & Co., Research Division Rohit Kulkarni - ROTH Capital Partners, LLC, Research Division Yanfang Jiang - The Benchmark Company, LLC, Research Division Siddharth Havaldar Presentation Operator Hello, everyone, and thank you for joining us for Marti Technologies First Half 2025 Conference Call. Before we begin, I'd like to mention that today's earnings release and slide presentation are available on Marti's Investor Relations website at ir.marti.tech, where you will also find links to our SEC filings, along with other information about Marti.
Monte Rosa secured a second major Novartis deal, adding $120M upfront and up to $5.7B in milestones to its cash reserves. GLUE advances MRT-8102, a NEK7 molecular glue degrader, into Phase 1 trials targeting inflammatory and cardio-immunology disorders, with key data expected in H1 2026. Strong financial position with $295.5M in cash as of June 2025, supported by multiple big pharma collaborations, funding operations into 2028.
| Software Industry | Information Technology Sector | Oguz Alper Oktem CEO | AMEX Exchange | 573134103 CUSIP |
| TR Country | 442 Employees | - Last Dividend | - Last Split | 29 Sep 2016 IPO Date |
Marti Technologies Inc. is a prominent player in the urban transportation sector, focusing on providing innovative mobility solutions to riders in Turkey. Founded in 2018 and headquartered in Istanbul, Marti has quickly established itself as a key entity in redefining how urban dwellers commute. Their dedication to offering convenient, eco-friendly, and efficient transportation options underscores their role in the modernization of urban mobility. By integrating technology with transportation, Marti Technologies not only simplifies the daily commute for thousands but also significantly contributes to reducing urban congestion and pollution.
Marti Technologies Inc. offers a diverse range of urban transportation solutions, catering to the varying needs of city goers. Their products and services include: